Sibutramine reduces feeding, body fat and improves insulin resistance in dietary‐obese male Wistar rats independently of hypothalamic neuropeptide Y

Authors:

Abstract
We studied the effects of the novel noradrenaline and serotonin (5‐HT) reuptake inhibitor sibutramine on feeding and body weight in a rat model of dietary obesity, and whether it interacts with hypothalamic neuropeptide Y (NPY) neurones. Chow‐fed and dietary‐obese (DIO) male Wistar rats were given sibutramine (3 mg kg−1 day−1 p.o.) or deionized water for 21 days. Sibutramine decreased food intake throughout the treatment period in both dietary‐obese rats (PPPPversus their untreated controls. Plasma leptin concentration was lower in sibutramine‐treated dietary‐obese rats (PPPPBritish Journal of Pharmacology (2001) 132, 1898–1904; doi:10.1038/sj.bjp.0704030

This publication has 46 references indexed in Scilit: